[Antithrombotic therapy in patients with prosthetic heart valves].
Anticoagulant therapy is an important component of treatment of patients with prosthetic heart valves. The article contains consideration of specific problems of antithrombotic therapy in patients with various types of prostheses and its tactics in different clinical situations. In the absence of national recommendations on the use of anticoagulants in these patients the authors suggest schemes of management based on recent European and American guidelines.
G E
GE
Gendlin
O A
OA
Tronina
G I
GI
Storozhakov
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D001780:Blood Coagulation Tests; D000077144:Clopidogrel; D016903:Drug Monitoring; D006349:Heart Valve Diseases / Q000503:physiopathology / Q000601:surgery*; D006350:Heart Valve Prosthesis / Q000145:classification / Q000592:standards; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000534:rehabilitation; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008991:Monitoring, Physiologic; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D013923:Thromboembolism / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin